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Background: Women in sub-Saharan Africa are vulnerable to acquiring HIV infection and reproductive tract infections.
Bacterial vaginosis (BV), a disruption of the vaginal microbiota, has been shown to be strongly associated with
HIV infection. Risk factors related to potentially protective or harmful microbiota species are not known.
Methods: We present cross-sectional quantitative polymerase chain reaction data of the Lactobacillus genus, five
Lactobacillus species, and three BV-related bacteria (Gardnerella vaginalis, Atopobium vaginae, and Prevotella bivia)
together with Escherichia coli and Candida albicans in 426 African women across different groups at risk for HIV.
We selected a reference group of adult HIV-negative women at average risk for HIV acquisition and compared
species variations in subgroups of adolescents, HIV-negative pregnant women, women engaging in traditional
vaginal practices, sex workers and a group of HIV-positive women on combination antiretroviral therapy. We
explored the associations between presence and quantity of the bacteria with BV by Nugent score, in relation to
several factors of known or theoretical importance.
Results: The presence of species across Kenyan, South African and Rwandan women was remarkably similar and
few differences were seen between the two groups of reference women in Kenya and South Africa. The Rwandan sex
workers and HIV-positive women had the highest G. vaginalis presence (p = 0.006). Pregnant women had a higher
Lactobacillus genus mean log (7.01 genome equivalents (geq)/ml) compared to the reference women (6.08 geq/ml).
L. vaginalis (43%) was second to L. iners (81.9%) highly present in women with a normal Nugent score. Recent sexual
exposure negatively affected the presence of L. crispatus (<0.001), L. vaginalis (p = 0.001), and Lactobacillus genus
(p < 0.001). Having more than one sexual partner in the last three months was associated with an increased
prevalence of G. vaginalis (p = 0.044) and L. iners (p = 0.001).
Conclusions: Although the composition of species across the studied African countries was similar, the
presence of protective species i.e. L. crispatus and L. vaginalis in women with a normal Nugent score appeared
lower compared to non-African studies. Furthermore, Lactobacillus species were negatively affected by sexual
behavioural. Strategies to support protective Lactobacillus species are urgently needed.
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Bacterial vaginosis (BV) has been consistently associated
with an increased risk of HIV infection and other sexu-
ally transmitted infections (STI) [1] as well as adverse
clinical outcomes such as pelvic inflammatory disease
[2], miscarriage [3], septic postpartum and neonatal
infections [4]. BV can increase the risk of other STI
which are in turn associated with HIV acquisition, in-
cluding human papilloma virus and herpes simplex virus
type 2 (HSV-2) infection [5-7]. While BV is a common
condition worldwide, the highest prevalence is seen in
sub-Saharan countries where HIV prevalence is highest
[8]. BV is best described as a disruption of the vaginal
microbiota or as a vaginal bacterial dysbiosis. It is charac-
terised by a reduction or a replacement of the protective
Lactobacillus species by an overgrowth of other anaerobic
bacteria [9,10].
Advances in molecular technologies, such as polymer-
ase chain reaction (PCR) based techniques, have pro-
vided us with new insights and a more detailed
characterisation of the vaginal microbiota; however, the
aetiology of BV remains poorly understood. Data on the
composition of the vaginal microbiota of African popu-
lations from regions with generalised HIV epidemics is
still very limited. In order to design efficient biomedical
interventions we need a better knowledge of the varia-
tions of the vaginal microbiota in healthy women at
average risk of HIV infection and in women at high risk
of HIV infection [11]. Further research is needed to
address how the composition of the vaginal microbiota
determines optimal vaginal and reproductive health.
This knowledge may advance the development of novel
interventions to prevent new HIV infections and address
biological vulnerability in young adolescent women.
Our study examined individual vaginal bacterial spe-
cies in women in sub-Saharan Africa and investigated
correlations with vaginal health and associated factors.
This paper will report cross-sectional quantitative PCR
data of the Lactobacillus genus and the five most preva-
lent vaginal Lactobacillus species [12,13] as well as three
BV-related bacteria (Gardnerella vaginalis, Atopobium
vaginae, and Prevotella bivia), and Escherichia coli and
Candida albicans in groups of women in sub-Saharan
Africa. To address the research gap described above we
studied the presence and concentrations of the species
in women at different risk for HIV infection. Wequantified the species in a reference group of adult HIV-
negative women at average risk for HIV acquisition and
compared species variations in subgroups of HIV-
negative pregnant women, adolescents, women engaging
in intravaginal practices, sex workers and a group of
HIV-positive women on combination antiretroviral ther-
apy. We explored the associations between presence and
concentrations of the bacteria with country, group, and
in relation to several factors of known or theoretical im-
portance e.g. recent sexual exposure including a seminal
plasma biomarker [14], current contraceptive use, and
reproductive tract infections (RTI).
Methods
Study design
A total of 430 women were enrolled at three study sites
in Mombasa, Kenya (KE), Kigali, Rwanda (RW) and
Johannesburg, South Africa (SA) in 2010–2011 [15].
Participants were enrolled in the cohort in one of six
pre-defined study groups: a reference group of 219
non-pregnant HIV-negative women (KE 110; SA 109),
and pregnant women (KE 30; SA 30), adolescents (KE 30;
SA 30), women practicing intravaginal practices (SA 30),
self-declared sex workers (RW 30) or HIV-positive women
(RW 30).
Population
The reference group consisted of women (18–35 years)
who were at average risk for HIV acquisition, did not en-
gage in traditional intravaginal practices and were not
pregnant. The pregnant women were less than 14 weeks
gestation. The non-pregnant adolescents were 16 or
17 years old. The non-pregnant women engaging in trad-
itional intravaginal practices inserted substances (cloth/
lemon juice/detergents) other than water and/or fingers to
clean, dry or tighten the vagina on a regular basis. The
remaining HIV-negative women consisted of non-
pregnant self-declared sex workers. The HIV-positive
women were on antiretroviral treatment for at least
6 months, were currently asymptomatic and had a CD4
count of more than 350 cells/μl. Recruitment was as fol-
lows: healthy women for inclusion in the reference groups
were recruited primarily through women’s groups and
subsequent snowballing in Mombasa County and through
primary health care clinics in inner city Johannesburg.
Women practicing intra-vaginal practices were identified
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at antenatal clinics in Mombasa County and inner city
Johannesburg. Adolescents were recruited from youth
groups in Mombasa County and from youth-friendly
clinics in inner city Johannesburg. In Kigali, sex workers
were recruited from the sex worker community and from
a previous prospective HIV-incidence cohort at RU
[16,17], using community mobilizers; and HIV-positive
women were recruited from the Muhima hospital public
HIV treatment clinic.
Clinic visit and laboratory procedures
The screening and eligibility assessment included testing
for HIV infection, RTI (Chlamydia trachomatis (CT),
Neisseria gonorrhoea (NG), Trichomonas vaginalis (TV),
HSV-2 and syphilis, urinary tract infection and cervical
dysplasia by Pap smear. Women were enrolled on day 9
(+/− 2 days) of the menstrual cycle with a maximum of
two months after the screening visit. All visits were con-
ducted by a qualified person and done in the language
chosen by the participant. An interview was conducted
on sexual behaviour and vaginal practices. Next, a phys-
ical and vaginal speculum examination was carried out
by a clinician, including colposcopy. Vaginal swabs for
quantitative polymerase chain reaction (qPCR) analysis
were taken at the enrolment visit before any other sam-
ples to avoid contamination. More details on visits and
procedures have been described previously [15]. Vaginal
swabs (Copan Diagnostics, Inc., Murrieta, USA) were
shipped in batches using a temperature-monitored dry
shipper to the central laboratory at the Institute of Trop-
ical Medicine (ITM) in Antwerp, Belgium. Vaginal
Gram-stained smears were scored at the ITM using the
Nugent method in which a Nugent score of 7–10 is clas-
sified as positive for BV, 4–6 is classified as intermediate
and 0–3 indicates a normal vaginal microbiota [18]. For
the quantification of vaginal species, two vaginal swabs
per woman were taken and stored at – 80°C until DNA
extraction. The swabs were thawed for 30 minutes at
room temperature and diluted phosphate buffered saline
(PBS) (1,200 μl; 1 part PBS and 9 parts saline, pH 7.4)
was added to each swab and vortexed for 15 seconds.
One ml of each suspension was pooled to a final volume
of 2 ml. An aliquot of 250 μl was used for DNA extrac-
tion on the Abbott m24sp automated extraction plat-
form (Abbott, Maidenhead, United Kingdom) according
to the manufacturer’s instructions. 200 μl of eluted DNA
was stored at −80°C for the qPCR assays (Additional file 1).
The eluted swab suspension was tested for the presence
of prostate-specific antigen (PSA) using the Seratec
PSA semiquant assay (Seratec Diagnostica, Göttingen,
Germany). A volume of 150 μl of the eluted swab sus-
pension was centrifuged for 10 min at 13,000 × g. After
centrifugation, 120 μl of supernatant was used fortesting according to the manufacturer’s instruction.
The vaginal pH was measured using pH 3.6-6.1 paper
strips pressed against the vaginal wall during the pelvic
examination (Macherey-Nagel pH Fix 3.6-6.1, Düren,
Germany). The RTI diagnostic tests used in this study
have been described before [15].
Quantitative PCR of selected organisms
We designed or selected primers targeting the following
genus and species which have previously been shown to
be important members of the vaginal microbiota [19-22]:
Lactobacillus genus, L. crispatus, L. iners, L. jensenii, L.
gasseri, L. vaginalis, Gardnerella vaginalis, Atopobium va-
ginae, Prevotella bivia, E. coli [23], and C. albicans [10].
qPCR was performed at the ITM and at the University of
Ghent, Ghent, Belgium, as follows: at the ITM, for Lacto-
bacillus genus, L. crispatus, L. iners, L. jensenii, L. gasseri,
and L. vaginalis, the 25 μl PCR mixture contained 12.5 μl
Rotor-Gene SYBR Green RT-PCR Master mix (Rotor-Gene
SYBR Green PCR Kit, Qiagen, Venlo, The Netherlands),
5 μl DNA extract, 0.5-1.0 μM of their respective primers
(Integrated DNA Technologies, Leuven, Belgium), and
RNase-Free Water provided with the Rotor-Gene SYBR
Green PCR kit [13,21,22,24,25]. The amplification reac-
tions were performed with the Rotor Gene Q MDx 5 plex
(Qiagen, Venlo, The Netherlands). The qPCR reactions, at
the University of Ghent, for A. vaginae, G. vaginalis, P.
bivia and E. coli were performed in a reaction volume of
10 μl, containing 5 μl of LightCycler 480R SYBR Green I
Master (Roche Applied Science, Basel, Switzerland),
0.2-1.25 μM of their respective primers (Eurogentec,
Liege, Belgium) and 2 μl of DNA extract [19,22,26,27].
Amplification was carried out on the LightCycler480®
and the LightCyclerR 480 Software Version 1.5 (Roche,
Basel, Switzerland). Standard curves were constructed
for each of the organisms with 6 standards by a tenfold
dilution of the DNA stock in HPLC grade water. DNA
of the lactobacilli was extracted from cultures of L. cris-
patus LMG 9479T, L. gasseri LMG 9203T, L. iners LMG
18914T, L. jensenii LMG 6414T and L. vaginalis LMG
12891T grown at 35°C ±2°C on Columbia agar base
(BBL, Becton Dickinson, Erembodegem, Belgium) and
5% horse blood under anaerobic conditions (Anaerocult
A, Merck, VWR International, Leuven). The DNA was ex-
tracted from cultures of A. vaginae CCUG 38953T, G.
vaginalis ATCC14018T, E. coli ACM1803T grown on TSA
and 5% sheep blood (Becton Dickinson, Erembodegem,
Belgium) and P. bivia ATCC29303T grown on Columbia
agar (Becton Dickinson, Erembodegem, Belgium) at
37°C ±2°C under anaerobic conditions (BugBox, Led-
Techno, Heusden-Zolder, Belgium). After extraction,
the DNA concentrations were determined using
NanoDrop (Thermo Fisher scientific, Erembodegem,
Belgium). The genomic concentrations were calculated
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Both the standard curves and samples were run in
duplicate. The number of bacteria was expressed as
genome equivalents per ml (geq/ml).
Data analysis
Data analysis was performed using SAS 9.4 and R 3.0.1.
Each participant contributed a single data point for each
analysis. Data from the enrolment visit was used except
for RTI diagnoses and information about sex partners,
which was collected at screening. The study population
characteristics and reproductive health and vaginal
microbiota data (including vaginal pH, Nugent scores,
and qPCR bacterial presence and concentrations in log
geq/ml) are described as medians with ranges for con-
tinuous variables and concentrations and percentages for
categorical variables. qPCR data was expressed categor-
ically as presence/absence, or alternatively presence was
divided into three separate categories: Not quantifiable
(1600 to 16.000 geq/ml), <106 geq/ml, ≥106 geq/ml. For
quantifiable levels, mean and SD were calculated. A
positive PSA result included both strong and weak reac-
tions. We explored bivariate associations with chi-
squared tests of the presence/absence of each bacterial
species (Lactobacillus genus excluded) with the follow-
ing variables: country, group, age, parity, lifetime num-
ber of sexual partners, number of sexual partners in the
last three months, reported recent vaginal sex, seminal
factor PSA presence, colposcopic findings e.g. petechiae,
erythema, presence of ectopy, HSV-2 serology, RTI (ex-
cluding HIV, HSV-2, Candida), products used to wash/
cleanse/dry/tighten, intravaginal cleansing during bathing,
contraception, recent antibiotic use (excluding cotrimoxa-
zole prophylaxis for the prevention of HIV-associated
opportunistic infections), BV, and vaginal pH. For
Lactobacillus genus we performed a simple linear
regression analysis including the variables defined
above. In the multivariate logistic regression, we report
adjusted odds ratio (AOR) and 95% confidence inter-
vals (CI); all variables meeting a p-value of ≤0.05 in the
bivariate analysis were included, removing variables
with a p-value of <0.05 in a stepwise manner. For
Lactobacillus genus we performed a multiple linear re-
gression analysis, reported as adjusted difference in
means, including the variables meeting a p-value of
≤0.05 from the simple regression analysis. We also con-
structed a multivariate logistic regression model that
included selected species and clinically relevant vari-
ables to improve the interpretation of the data. The
species and variables included in this model were: L.
crispatus, L. iners, G. vaginalis, A. vaginae, Lactobacil-
lus genus, parity, PSA, number of sexual partners
within the last three months, reported intravaginal
cleansing during bathing, recent antibiotic use, andcontraception use. We included intravaginal cleansing
during bathing as this was a highly prevalent behaviour in
our study population. We further included contraceptive
use in the model because the controversial discussion of
the effect of progesterone depot on the acquisition of HIV.
This analysis was performed on the reference group and
on all women.
Ethics statement
Written information and consent forms in the local lan-
guage were provided. After the interview, the participants
and, in case they were of minor age/not emancipated (age
below 18 in South Africa and Kenya and below 21 in
Rwanda), the parents or guardians were asked to confirm
their willingness to participate in the study by signing or
marking the consent form. The protocol was approved by
the Kenyatta National Hospital Ethical Review Committee,
Kenya; the Human Research Ethics Committee, University
of the Witwatersrand, SA; the Rwanda National Ethics
Committee, Rwanda; the Institutional Review Boards of
the Institute of Tropical Medicine in Antwerp, of Ghent
University, and of the University Teaching Hospital in
Antwerp, Belgium. In addition the study was approved by
the National Council on Science and Technology in
Kenya; the SA Department of Health; and the National
AIDS Control Commission in Rwanda.
Results
qPCR data were not available for four women leaving
426 women for the analysis. Nugent score data were
available for 387 of the 426 women due to unreadable
Gram stain smears.
The mean age of the reference group was 25 years
(Additional file 2). Women in the other study groups
had a similar mean age (24–26 years), except for the
adolescents who were 16–17 years old, and the HIV-
positive women who had a mean age of 31 years.
Contraceptive use in the reference group was 80.4%; the
most commonly used methods were condoms (24%) and
progestin-only injections (36%). Among adolescents,
overall contraceptive use was low (65%); the most com-
mon method was condoms (50%). Seventy-five per cent
of women in the reference group had one or more chil-
dren. Parity was highest in the vaginal practices group
(84%), the sex workers (97%) and HIV-positive women
(90%). Intravaginal cleansing during bathing was fre-
quently in all groups (including the reference group),
with exception of pregnant women who reported less
intravaginal cleansing (28%). While the majority of
women stated having one sex partner in the past three
months (reference group 90%), with exception of sex
workers who reported many more partners. Systemic
antibiotics were used by 62 women (14%) within 14 days
prior to the enrolment visit. The last day of antibiotic
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enrolment visit.
Prevalence of BV, pH and PSA
Overall, 57.5% of women presented with a normal
Nugent score, 7.1% with an intermediate score and
35.4% with a BV score. The BV prevalence was 33% in
the reference group, 30% for pregnant women, 30% in
adolescents, 37% in vaginal practice users, 48% for
women living with HIV, and 68% for sex workers. The
overall mean vaginal pH was 4.7 (SD = 0.7) with the
majority (68%) of women having a pH between four and
five (Additional file 3). Ten per cent of women had a pH
below four. PSA was present for 39% of the reference
group, 38% in the adolescents, 44% among women living
with HIV, 45% in the vaginal practices users, 56% in
pregnant women, and 57% in sex workers. Further
results by group are presented in Table 1.
A comparison of the presence and concentrations of
species and Lactobacillus genus across countries and
groups
The presence of species and Lactobacillus genus across
Kenyan, South African and Rwandan women was
remarkably similar and there was no evidence of differ-
ences between the two large groups of reference women
in Kenya and South Africa (Figure 1, Tables 1 and 2,
Additional file 3). There was strong evidence for differ-
ences among the Rwandan sex worker group. The
Rwandan sex workers had the highest G. vaginalis pres-
ence (p = 0.006) and the lowest L. jensenii presence
(6.7% RW, 19% KE, 21.7% SA; p = 0.031). Also, E. coli
was present in 70% of Rwandan sex workers compared
to 20% in Rwandan HIV-positive women, 25% in women
in Kenya and 26% in SA (p = 0.009). High concentrations
of Lactobacillus genus (>106 geq/ml) were present in
69% of all women and low concentrations (103 to 106
geq/ml) in 15% (a distribution of the species log concen-
trations is shown in Additional file 4). L. iners, L. crispatus,
L. jensenii, L. vaginalis, and L. gasseri were detected in
high concentrations (>106 geq/ml) in 58%, 20%, 13%, 10%
and 3% of women, respectively. In the reference group
91.7% of women had lactobacilli detected as measured by
Lactobacillus genus-level PCR. This proportion was lowest
for HIV-positive women (80%) and for adolescents
(86.4%). The Lactobacillus genus mean log was 6.39 geq/
ml for Kenyan women which was higher than the mean
log for Rwandan (5.93 geq/ml) and South African (5.95
geq/ml) women (p = 0.235). Pregnant women, in particular
in Kenya, had a higher mean log of Lactobacillus genus
(7.01 geq/ml) compared to the reference women (6.08
geq/ml; p = 0.013). Interestingly, South African adoles-
cents had the lowest mean log Lactobacillus genus (4.26
geq/ml, p < 0.001) whereas Kenyan adolescent had a highmean log of 6.97 geq/ml when comparing groups and
country. Further, adolescents had low P. bivia presence
compared to the reference group (p < 0.001). C. albicans
was detected in 12% of reference women and similar pro-
portions were found in the other groups (p = 0.524).
Reproductive health, sexual behaviour and the presence
and concentrations of qPCR microbiota
Parity was negatively associated with L. vaginalis and L.
iners in a bimodal way. Having one or two children was
associated with a lower prevalence of L. vaginalis
(22.4%) compared to women with no children (34.2%)
and women with more than two children (33.3%) (AOR
0.56; 95% CI 0.35,0.91; p = 0.05). This association was
similar for the reference group (20% vs 37.9% vs 38.5%;
AOR 0.41; 95% CI 0.20, 0.82). Further, having more than
two children was associated with lower detection of L.
iners (AOR 0.35; 95% CI 0.18,0.66; p = 0.002). Finally,
having any number of children was strongly associated
with the presence of C. Albicans (AOR 3.7; 95% CI 1.59,
8.61 for 1–2 children and AOR 2.54; 95% CI 0.85,7.56
for more than 2 children; p = 0.006). We found several
sexual behavioural factors associated with presence and
concentrations of species. L. crispatus (AOR 0.33; 95%
CI 0.20,0.56; p < 0.001) and L. vaginalis presence (AOR
0.47; 95% CI 0.3,0.75;p = 0.001) was negatively associated
with recent sexual exposure as measured by PSA detec-
tion, as were the Lactobacillus genus concentrations (ad-
justed difference in means −1.01; 95% CI:-1.51,-0.51; p <
0.001). This strongly negative association of L. crispatus
and PSA remained in the sub-analysis of the reference
group (AOR 0.35; 95% CI 0.17,0.72; p = 0.002). Addition-
ally, having more than one sexual partner in the last
three months was positively associated with the presence
of E. coli (51.1% vs 23.1%; OR 3.48, 95% CI 1.18,10.30; p
= 0.003), L. iners (66.7% vs 42.3%; AOR 3.1, 95% CI 1.12,
8.57; p = 0.001) and G. vaginalis (66.7% vs 34.6%; AOR
3.57, 95% CI 1.28,9.97; p = 0.045). There was no evidence
of an association between the number of lifetime part-
ners and the presence of species except for a modest
positive association with the presence of P. bivia and E.
coli. The reporting of recent vaginal sex, similarly, was
only associated with P. bivia.
The detection of HSV-2 antibodies was negatively as-
sociated with L. crispatus in all women; additionally
HSV-2 was negatively correlated with Lactobacillus
genus (mean log −0.74; 95% CI: −1.46,-0.02; p = 0.045) in
the reference group. The detection of an RTI at screen-
ing (CT, NG, TV, or syphilis), was negatively associated
with L. crispatus, L. jensenii (9.6% vs 20.4%) and L. vagi-
nalis, and positively associated with G. vaginalis and A.
vaginae presence. None of the variables: abnormal col-
poscopic findings, products used to wash/cleanse/dry/
tighten, or cleansing during bathing, showed an
Table 1 Presence and concentrations of vaginal microbiota species
Reference group Pregnant women Adolescents Intravaginal
practices
Sex
workers
HIV-
positive
Kenya
N = 109
South Africa
N = 108
Kenya
N = 30
South Africa
N = 30
Kenya
N = 29
South Africa
N = 30
South Africa
N = 30
Rwanda
N = 30
Rwanda
N = 30
Presence of species
by qPCR
N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%)
Lactobacillus genus 101(93) 98(91) 30(100) 30(100) 27(93) 24(80) 28(93) 28(93) 24(80)
Lactobacillus crispatus 29(27) 26(24) 6(20) 7(23) 11(38) 6(20) 5(17) 5(17) 5(17)
Lactobacillus iners 75(69) 82(76) 24(80) 23(77) 23(79) 20(67) 26(87) 18(60) 19(63)
Lactobacillus jensenii 19(17) 25(23) 6(20) 10(23) 7(24) 2(7) 6(20) 1(3) 3(10)
Lactobacillus gasseri 7(6) 8(7) 3(10) 3(10) 4(14) 2(7) 2(7) 4(13) 3(10)
Lactobacillus vaginalis 33(30) 28(26) 9(30) 7(23) 14(48) 7(23) 5(17) 8(27) 9(30)
Gardnerella vaginalis 59(54) 49(45) 14(47) 15(50) 17(59) 19(63) 16(53) 23(73) 21(70)
Atopobium vaginae 46(42) 37(34) 9(30) 11(37) 10(34) 19(43) 11(37) 17(57) 14(47)
Prevotella bivia 97(89) 83(77) 29(97) 21(70) 24(83) 12(40) 22(63) 30(100) 27(70)
Escherichia coli 28(26) 29(27) 6(20) 10(23) 8(28) 4(13) 9(30) 21(70) 6(20)
Candida albicans 15(14) 12(11) 4(13) 1(3) 3(10) 0 5(17) 4(13) 3(10)
Vaginal species
concentrations by qPCR1
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Lactobacillus genus 6.4(2.1) 6.9(1.7) 7.5(1) 6.5(2.3) 7.5(1.1) 5.3(2.5) 6.4(2.1) 7.1(1.7) 6.5(2.4)
Lactobacillus crispatus 6.8(2.2) 7.2(1.6) 8(0.4) 7.6(1.5) 7.3(2.2) 7.1(1.3) 7.5(1.3) 7.8(1.1) 4.7(3.4)
Lactobacillus iners 6.6(2.2) 7(2) 7.6(1.1) 6.9(1.6) 7.4(1.7) 4.9(3.1) 6.7(2.3) 8.1(1.1) 7.3(2.4)
Lactobacillus jensenii 5.6(2.5) 6.3(1.9) 6.6(1) 7.7(0.9) 5.5(3.1) 3.5(3.6) 5(3.2) 8.3(NA) 6.3(1)
Lactobacillus gasseri 3.3(2.9) 5.3(1.9) 6.3(1.3) 5.1(3.8) 4.7(2.5) 6.4(0.4) 3.8(4) 4.1(3.5) 1(NA)
Lactobacillus vaginalis 2.6(3) 3.8(3.2) 3.9(3.4) 4.4(3.9) 5.2(2.8) 6.2(0.7) 3.1(4.4) 4.8(3.2) 4.1(2.7)
Gardnerella vaginalis 5.4(1.1) 5.3(0.9) 5.5(1.2) 5.2(0.9) 5.5(0.8) 4.6(1.2) 5.2(1.4) 6.2(1) 5.6(1)
Atopobium vaginae 5.5(1.8) 5.1(1.5) 7(1) 5.2(1.7) 5.4(2.4) 5(1.7) 5.7(1.3) 6.6(1.8) 5.5(1.5)
Prevotella bivia 3.1(1.2) 3.2(1.1) 3.1(1.3) 3.3(0.9) 3.3(1.3) 3.2(1.1) 3.5(1.1) 3.6(1.1) 3.3(1)
Escherichia coli 5.2(0.4) 5.1(0.6) 5(0.5) 5.2(0.5) 5.1(0.4) 4.8(0.3) 4.9(0.3) 5.3(0.6) 5.9(1.1)
Candida albicans 4.9(1.3) 5.1(0.7) 5.7(1) 4.6(NA) 6(0.7) 0(NA) 5.3(0.8) 5.4(1.2) 4.9(0.2)
Nugent score2 and
vaginal pH
Vaginal pH 5.1(0.9) 4.5(0.6) 4.8(0.8) 4.3(0.5) 4.7(0.7) 4.4(0.6) 4.6(0.6) 5.1(0.6) 4.7(0.6)
Nugent 0–3: normal 55(56) 63(66) 19(68) 18(62) 18(67) 13(45) 16(59) 6(24) 13(48)
Nugent 4–6: intermediate 8(8) 6(6) 1(4) 2(7) 4(15) 4(14) 1(4) 2(8) 1(4)
Nugent 7–10: bacterial
vaginosis
36(36) 27(28) 8(29) 9(31) 5(19) 12(41) 10(37) 17(68) 13(48)
Quantitative PCR data was available for 426 of the 430 women. 1mean (SD) quantity log concentrations of the microbiota for women who had that particular
species detected and quantified as log genome equivalents/ml. 2Nugent score data were available for 387 of the 426 women due to unreadable Gram stained
slides. qPCR: quantitative polymerase chain reaction.
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associated with increased E. coli presence (35.9% vs 22%;
AOR 1.78, 95% CI 1.12,2.83; p = 0.002). Additionally, re-
ported antibiotics use in the past 14 days was associated
with a higher presence of G. vaginalis (AOR 2.23; 95%
CI 1.33,3.74; p = 0.035) and A. vaginae (AOR 1.79; 95%
CI 1.11,2.90; p = 0.017). And finally, C. albicans was
more often present in women using progesterone-only(OR 1.96; 95% CI 1.0,3.86) or combined hormones (OR
2.47; 95% CI 1.06,5.81; p = 0.050).
Association with Nugent score and pH
As expected, there was a strong positive association be-
tween L. crispatus (34.8% vs 5.8%), L. jensenii (28.5% vs
4.4%), L. vaginalis (43% vs 6.6%), L. iners (81.9% vs
67.2%) and L. gasseri (10.4% vs 3.6%) and a Nugent score
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Figure 1 Presence of microbiota species by study group and bacterial vaginosis status. R: reference group; P: pregnant women; A: adolescent
women; V: women using vaginal practices other than water and soap; HIV-: self-declaring sex workers; HIV+: HIV-positive women. Black bar: ≥106
genome equivalents (geq)/ml; Grey bar: <106 geq/ml (103 geq/ml for P. bivia); White bar: present but not quantifiable (1600 to 16.000 geq/ml).
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ence group (p < 0.001 to p = 0.023) and in all women
(p < 0.001 to p = 0.042) (Figure 1). Similarly, there was a
strong positive association between A. vaginae (94.2% vs
28.1%) and G. vaginalis (82.5% vs 13.6%) and a Nugent
score of 7–10 compared to Nugent score 0–3 in both all
women and in the reference group (p < 0.001). E. coli
presence was higher (51.7%) in women with an inter-
mediate BV score (p = 0.011) compared to women with
no BV (28.1%) and women with BV (24.1%). There was
no evidence of an association between P. bivia and C.
albicans and Nugent score. Vaginal pH was negatively
correlated with Lactobacillus species, with the exception
of L. iners. For example, L. crispatus was present in
67.4% of women with a pH below 4 and in 9.8% of
women with a pH above 5.5 and for L. vaginalis propor-
tions were 58.1% vs 11.8%. In contrast, the proportions
for L. iners were 74.4% vs 70.6%.
A model summarising the associations between species
and relevant clinical variables
There was a negative association between L. iners and
increased parity in both the reference women and all
women (Table 3 presents OR and 95% CIs). For both the
reference group and all women, the negative association
between the seminal factor PSA and L. crispatus wasconfirmed, as well as a reduced Lactobacillus genus con-
centration by about one log. Similarly, for the reference
group and all women, having more than one sexual part-
ner in the last three months was positively associated
with L. iners and G. vaginalis presence. Recent antibiotic
use was associated with a higher prevalence of G. vagi-
nalis and A. vaginae in all women, but this association
was not seen in the analysis of the reference women.
There was no evidence of an association with intravagi-
nal cleansing during bathing in the analysis for all
women, but there was a strong association with the
microbiota in the reference women: a negative associ-
ation with A. vaginae and positive association with
Lactobacillus genus. In the reference group, women
using progesterone-only and combined hormones had a
lower presence of A. vaginae and G. vaginalis as com-
pared to women not using contraceptives or using none
hormonal contraceptive methods.
Discussion
This study characterised key microbiota in the female
genital tract, and compared their presence and concen-
trations among healthy women at average risk to those
at high risk of HIV infection in three sites in sub-
Saharan Africa. The presence of species and Lactobacil-
lus genus across Kenyan, South African and Rwandan
Table 2 Univariate and multivariate analysis of factors associated with vaginal Lactobacillus, and BV-related species presence1
N = 426 L. crispatus L. iners L. vaginalis G. vaginalis A. vaginae P. bivia
% OR (CI) % OR (CI) % OR (CI) % OR (CI) % OR (CI) % OR (CI)
Country p = 0.207 p = 0.084 p = 0.126 p = 0.006 p = 0.182 p = <0.001
Kenya 27.4 72.6 33.3 53.6 Ref 38.7 89.3 Ref
Rwanda 16.7 61.7 28.3 73.3 2.38(1.25,4.55) 51.7 85.0 0.68(0.29,1.61)
South Africa 22.2 76.3 23.7 50.0 0.87(0.57,1.31) 39.4 69.7 0.28(0.16,0.49)
Group p = 0.580 p = 0.174 p = 0.591 p = 0.026 p = 0.190 p = <0.001
Reference group 25.3 72.4 28.1 49.8 Ref 38.2 82.9 Ref
Pregnant women 21.7 78.3 26.7 48.3 0.94(0.53,1.67) 33.3 83.3 1.03(0.48,2.21)
Adolescents 28.8 72.9 35.6 61.0 1.58(0.88,2.84) 49.2 61.0 0.32(0.17,0.61)
Intravaginal practices 16.7 86.7 16.7 53.3 1.15(0.54,2.48) 36.7 73.3 0.57(0.23,1.37)
Sex workers 16.7 60.0 26.7 76.7 3.32(1.37,8.05) 56.7 100 No estimate
HIV-positive women 16.7 63.3 30.0 70.0 2.35(1.03,5.37) 46.7 70.0 0.48(0.2,1.37)
Age p = 0.376 p = 0.046 p = 0.554 p = 0.640 p = 0.556 p = <0.001
<18 years 28.8 72.9 Ref 35.6 61.0 49.2 61.0 Ref
18 – 24 years 20.3 77.0 1.25(0.63,2.49) 25.7 56.1 40.5 84.5 3.98(1.93,8.24)
25 – 29 years 21.7 75.4 1.14(0.57,2.27) 27.5 52.2 39.1 83.3 3.37(1.62,7.03)
30 years or more 28.4 60.5 0.57(0.28,1.18) 28.4 51.9 38.3 77.8 2.46(1.08,5.58)
Parity p = 0.106 p = 0.001 p = 0.03 p = 0.418 p = 0.840 p = 0.164
0 27.5 76.5 Ref 34.2 Ref 54.4 40.3 75.2
1 – 2 19.2 75.7 0.96(0.59,1.56) 22.4 0.56(0.35,0.89) 57.0 42.1 83.2
>2 28.6 54.0 0.36(0.19,0.67) 33.3 0.96(0.51,1.79) 47.6 38.1 77.8
RTI2 p = 0.014 p = 0.406 p = 0.031 p = 0.019 p = 0.003 p = 0.977
No RTI 25.8 Ref 72.0 30.3 Ref 52.1 Ref 37.7 Ref 79.6
1 or more RTI 12.3 0.40(0.19,0.85) 76.7 17.8 0.50(0.26,0.95) 67.1 1.88(1.10,3.19 56.2 2.12(1.27,3.53) 79.5
Nr of sexual partners last 3 months3 p = 0.060 p = <0.001 p = 0.669 p = 0.033 p = 0.129 p = 0.053
0 42.3 42.3 Ref 30.8 34.6 Ref 30.8 76.9 Ref
1 22.5 75.8 4.27(1.89,9.64) 27.3 54.6 2.28(0.99,5.24) 40 78.0 1.07(0.41,2.74)
>1 20.0 66.7 2.73(1.01,7.37) 33.3 66.7 3.78(1.36,10.46) 53.3 93.3 4.2(0.95,18.54)
Seminal factor PSA present4 p = <0.001 p = 0.464 p = <0.001 p = 0.259 p = 0.308 p = 0.128
No 32.1 Ref 70.9 34.6 Ref 52.1 38.5 82.9
Yes 13.2 0.32(0.19,0.54) 74.2 19.8 0.47(0.3,0.73) 57.7 43.4 76.9
Results that remained significant (using a p = 0.05 cut-off) in the multivariate logistic regression are depicted in bold. 1: Univariate analysis with p-values from chi-squared tests; 2RTI: excluding HIV, HSV-2, Candida.
3Data collected at the screening visit up to two months before the enrolment visit. 4Prostate specific antigen present in vaginal fluid, including weak reaction. RTI: reproductive tract infections.
Jespers
et
al.BM
C
Infectious
D
iseases
 (2015) 15:115 
Page
8
of
14
Table 3 Factors associated with L. crispatus, L. iners, G. vaginalis, A. vaginae and Lactobacillus genus: results from a
multiple logistic regression model for the reference women and for all women
Reference women N = 217 L. crispatus L. iners G. vaginalis A. vaginae Lactobacillus genus*
OR (CI) OR (CI) OR (CI) OR (CI) Log concentrations (CI)
Parity p = 0.831 p = 0.003 p = 0.587 p = 0.265 p = 0.179
0 Ref Ref Ref Ref Ref
1 – 2 0.82(0.36,1.88) 0.43(0.18,1.05) 1.40(0.67,2.93) 1.81(0.85,3.86) −0.79(−1.67,0.10)
>2 1.01(0.36,2.86) 0.16(0.05,0.47) 1.07(0.41,2.75) 1.93(0.72,5.16) −0.91(−2.06,0.24)
Seminal factor present p = 0.003 p = 0.715 p = 0.773 p = 0.435 p = 0.016
No Ref Ref Ref Ref Ref
Yes 0.34(0.16,0.72) 1.13(0.58,2.23) 1.09(0.60,1.97) 1.27(0.69,2.34) −0.89(−1.61,-0.17)
Nr of sexual partners last 3 months1 p = 0.901 p = 0.049 p = 0.049 p = 0.204 p = 0.667
0 Ref Ref Ref Ref Ref
1 1.16(0.36,3.72) 3.90(1.27,11.94) 4.17(1.22,14.23) 2.14(0.63,7.32) 0.49(−0.84,1.83)
>1 0.74(0.06,9.56) 1.97(0.22,17.63) 3.12(0.34,28.91) 6.83(0.74,63.15) −0.15(−2.74,2.44)
Intravaginal cleansing during bathing p = 0.420 p = 0.208 p = 0.281 p = 0.023 p = 0.007
No Ref Ref Ref Ref Ref
Yes 1.33(0.66,2.65) 1.55(0.78,3.09) 0.72(0.39,1.31) 0.49(0.26,0.91) 1.01(0.28,1.75)
Contraception use p = 0.259 p = 0.368 p = 0.008 p = 0.015 p = 0.606
None/Non-Hormonal Ref Ref Ref Ref Ref
Hormonal 0.66(0.32,1.36) 1.39(0.68,2.82) 0.42(0.22,0.88) 0.44(0.22,0.86) 0.21(−0.58,0.99)
Recent antibiotic use p = 0.360 p = 0.704 p = 0.697 p = 0.383 p = 0.980
No Ref Ref Ref Ref Ref
Yes 0.63(0.23,1.73) 0.83(0.33,2.13) 1.18(0.51,2.72) 1.45(0.63,3.35) −0.01(−1.03,1.00)
All women N = 426 L. crispatus L. iners G. vaginalis A. vaginae Lactobacillus genus*
Parity p = 0.324 p = 0.002 p = 0.477 p = 0.793 p = 0.763
0 Ref Ref Ref Ref Ref
1 – 2 0.76(0.43,1.36) 0.94 (0.54,1.66) 1.13(0.69,1.84) 1.15(0.70,1.87) 0.03(−0.58,0.64)
>2 1.24(0.59,2.62) 0.33 (0.16,0.67) 0.75(0.39,1.46) 0.99(0.51,1.94) −0.19(−1.01,0.64)
Seminal factor present p = 0.001 p = 0.933 p = 0.744 p = 0.503 p = 0.001
No Ref Ref Ref Ref Ref
Yes 0.36(0.21,0.61) 1.01(0.63,1.61) 1.07(0.71,1.61) 1.13(0.75,1.70) −1.00 (−1.51,-0.49)
Nr of sexual partners last 3 months1 p = 0.319 p = 0.003 p = 0.022 p = 0.095 p = 0.310
0 Ref Ref Ref Ref Ref
1 0.50(0.21,1.17) 4.40 (1.86,10.41) 2.47 (1.02,5.98) 1.61 (0.64,4.02) 0.20(−0.85,1.25)
>1 0.51(0.17,1.58) 3.05 (1.06,8.79) 4.35 (1.48,12.74) 2.91 (0.99,8.61) 0.82(−0.46,2.10)
Intravaginal cleansing during bathing p = 0.408 p = 0.057 p = 0.557 p = 0.178 p = 0.099
No Ref Ref Ref Ref Ref
Yes 0.81(0.50,1.32 1.58 (0.99,2.53) 0.88(0.58,1.34) 0.75(0.50,1.14) 0.44 (−0.08,0.96)
Contraception use p = 0.224 p = 0.445 p = 0.293 p = 0.373 p = 0.125
None/Non-Hormonal Ref Ref Ref Ref Ref
Hormonal 0.70(0.41,1.22) 0.78(0.47,1.31) 0.83(0.52,1.30) 0.83(0.52,1.32) −0.53(−1.09,0.04)
Recent antibiotic use p = 0.110 p = 0.606 p = 0.054 p = 0.052 p = 0.832
No Ref Ref Ref Ref Ref
Yes 0.63(0.33,1.21) 0.65(0.38,1.13) 1.76 (0.98,3.15) 1.74 (1.00,3.03) −0.64(−1.26,-0.01)
Results that remained significant (using a p= 0.05 cut-off) in the model are depicted in bold. *: non- logistic regression model. qPCR: quantitative polymerase chain reaction.
1Data collected at the screening visit up to two months before the enrolment visit. Nr: number. The numbers in each category for the variables are listed in the Additional file 2.
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seen between the two large groups of reference women
in Kenya and South Africa. However, the sex workers
and HIV-positive women from Rwanda had the highest
G. vaginalis presence, and pregnant women had a higher
Lactobacillus concentration. Additionally, this study
found that recent sexual exposure negatively affected the
presence of L. crispatus, L. vaginalis, and Lactobacillus
genus, and that having more than one sexual partner in
the last three months was strongly associated with an in-
creased presence of G. vaginalis and L. iners.
This is the first study showing that, in addition to L.
crispatus, L. vaginalis may play an important role in the
health of the vaginal microbiota in African women. L.
vaginalis together with L. crispatus showed the strongest
association (p < 0.001) with a healthy Nugent score in
the reference group (i.e. adult, non-pregnant, non-sex
worker women) and in all women combined. L. vaginalis
was present in concentrations above 106 geq/ml for 36%
of the 28% of women with detectable L. vaginalis. We
previously demonstrated a L. vaginalis presence of 73%
in healthy and of 8% in women with BV in a study in
Belgium [13]. A recent study that characterized the
microbiota among seven women in the US by 16S rRNA
sequencing identified L. vaginalis, in 3 out of 7 healthy
women; however, L. vaginalis contributed to less than
0.05% of the communities [28]. In a study from Burkina
Faso, L. vaginalis represented only 0.5% of sequences in
a cluster of 30 participants with dominant genus Lacto-
bacillus, compared to 77% for L. iners and 11% for L.
crispatus [4]. In a study that compared vaginal micro-
biota between unspecified adult populations in Uganda
and Korea, L. vaginalis, detected by 16S rRNA after iso-
lation on Lactobacillus Rogosa SL agar, was common in
Uganda and absent in Korea, whereas L. crispatus was
common in both populations [29]. There is also mention
of the presence of L. vaginalis, detected by Randomly
Amplified Polymorphic DNA and 16S rRNA after isola-
tion on Rogosa agar, in a small Swedish study of 20
healthy women in the vagina as well as the rectum [30].
More research is needed to understand the role and
function of L. vaginalis, in addition to other Lactobacil-
lus species prevalent in the vaginal niche. Mendez-
Soares and colleagues performed functional genomics of
25 species of vaginal, gastrointestinal and food product
lactobacilli [31]. They described differences in genes en-
coding for proteins that interact with the host, as well as
other bacteria, between L. crispatus, L. iners, L. jensenii,
L. gasseri. This suggests that these species have different
mechanisms for interacting with their environment.
Also, it has been shown that different growth limiting
factors exist between species. Boskey and colleagues
showed in vitro that the growth limiting factor for L.
vaginalis was a depletion of a metabolite or the buildupof an unspecified toxic waste product; this is in contrast
to L. crispatus and L. gasseri in which the growth limit-
ing factor is the lowest point of acidity reached due to
species lactic acid production [32].
While several published papers confirm that lactoba-
cilli are the dominant species in a healthy vaginal envir-
onment and are replaced by other commensal anaerobes
(but remain present in very low numbers) in women
with BV, there is a paucity of qPCR data on Lactobacil-
lus genus and species in African populations. Individual
species have been characterised in several settings in the
US, Europe, Australia and Asia, yet we could identify
only three papers for sub-Saharan Africa presenting
quantitative data: two from East and one from West
Africa. In Niger, 241 asymptomatic women attending a
health care clinic were included [33]. Lactobacillus
genus was absent in 34 women with a diagnosis of BV
by Nugent score (14.2% of total women). HIV-positive
women in Kenya had a L. crispatus mean log concentra-
tion just below 6 (copies/swab) which is higher than the
4.7 log (geq/ml) that we observed in the HIV-positive
women in Rwanda [34]. Benning and colleagues retro-
spectively sequenced the 16S rRNA gene in 40 cervi-
covaginal lavage samples from a Rwandan cohort that
included HIV-positive women [35]. Compared to our
data in the HIV-positive women, they detected lower
presence of Lactobacillus genus (67% vs 80%), L. crispa-
tus (11% vs 17%), L. iners (50% vs 63%), and L. vaginalis
(11% vs 30%). These variations in results may be ex-
plained by the small sample size and by the difference in
methods used. Pregnancy has been shown to be associated
with low bacterial diversity and high levels of lactobacilli,
particularly L. crispatus [36,37]. The higher Lactobacillus
concentrations that we observed in the pregnant women
agrees with a longitudinal study in 22 pregnant, mostly
African American women, showing a higher abundance in
16S rRNA V1-V3 of Lactobacillus vaginalis, L. crispatus,
L. gasseri and L. jensenii as compared to 20 non-pregnant
women, of whom 10 were African American [38]. Simi-
larly, a US longitudinal study of 12 Caucasian healthy
women showed a stable Lactobacillus dominant vaginal
microbiome (16S rRNA V3-V5) throughout pregnancy
[39]. In future, larger and longitudinal studies are needed
to adequately characterise the vaginal microbiota among
women in sub-Saharan Africa.
L. iners was present in 82% of BV-negative, in 62% of
intermediate, and in 67% of BV-positive samples by
Nugent score. It is the only Lactobacillus species that
was present in high concentrations in samples that are
also characterised by high concentrations of A. vaginae
and G. vaginalis. In contrast with the other lactobacilli, L.
iners did not show an association with vaginal pH (p =
0.562) and therefore seems to be resilient to a less acidic
BV environment. Further, recent exploratory in vitro data
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iners [40]. L. iners has been detected as the dominant spe-
cies in some studies (e.g. in healthy White and Black
American women [41]); in combination with L. crispatus in
Japanese women [42], Chinese women [43], Estonian
women [44], and Caucasian Belgian women [13]; or to-
gether with multiple Lactobacillus species in non-Black
American women [41]. L. iners has also been shown to be
present, though to a lesser extent, in BV-positive samples in
other populations (e.g. 6.6% of sequences in Swedish
women) [45].
Sexual behaviours were shown to be associated with
concentration of vaginal microbiota. PSA, a validated
marker of recent unprotected sexual intercourse in the
past 72 hours, was strongly associated with a reduced
prevalence of L. crispatus and L. vaginalis and lower
concentrations of Lactobacillus genus. These data are
congruent with a contraceptive study which reported
that condom use was associated with higher L. crispatus
concentrations (+2 log geq/ml, p < 0.001) compared to
intra uterine device users or women using the rhythm
method [46]. This result supports the hypothesis that
the exposure to the alkaline semen alters the vaginal
microbiota. We reported an increased presence of G.
vaginalis and L. iners with more than ‘one sexual partner
in the last three months’. BV has been shown to be associ-
ated with exposure to a new partner in other reports
[47,48]. We could not explore this association due to a
low number of women reporting a new sex partner.
Recently, it has been postulated that certain subgroups of
G. vaginalis may cause a different clinical outcome
[49,50]. Therefore, a new partner could possibly introduce
a new G. vaginalis strain and lead to microbial instability.
In conclusion, we theorise that the combination of an
immediate decrease in Lactobacillus species initiated by
alkaline semen, and the acquisition of a new strain of BV-
associated bacteria may lead to incident BV episodes.
We detected a higher presence of Lactobacillus spe-
cies, with the exception of L. iners, for women with a
low pH. The association of pH with individual vaginal
species has not been described previously but a higher
abundance of lactobacilli has been associated with a
lower vaginal pH among 100 cycling Chinese women
[43], 494 asymptomatic Estonian women [44], and 396
asymptomatic North American women [20]. The median
pH observed in the reference groups was well above 4.2,
the cut-off for which values below are reported as nor-
mal [51]. The pH, measured in clinical studies as one of
the Amsel criteria, is not often described separately in
the literature and data is lacking for women in Africa
and in general. A median pH of 3.6 was described in a
Belgian healthy population of 141 women [52]. More-
over, the vaginal pH in different ethnic groups in North
America was as follows: Hispanic 5.0; black 4.7; Asian4.4 and white 4.2 [20] and for Estonian women the mean
value was 4.7 [44].
To our knowledge, the association of parity with a de-
crease in L. vaginalis and L. iners presence has not been
described previously. This suggests that pregnancy, a
period of high oestrogen status with high lactobacilli
presence, is followed by a reduction of certain strains of
the lactobacilli species. It is possible that the delivery
period could disrupt the stable vaginal lactobacillus
population attained during pregnancy. This hypothesis
needs further study. C. albicans was positively associated
with parity in our study. It is known to be associated
with pregnancy which may indirectly explain the associ-
ation with parity. However, a study in 500 Australian preg-
nant women showed no difference for vaginal candida
colonization and parity history [53]. This may indicate that
candida colonization does not normalize after delivery.
Though research has shown that intravaginal cleansing
is a risk factor for BV [54,55], we did not observe a
negative effect of the use of products to externally wash,
internally cleanse, or use of products for drying or tight-
ening on the presence or concentrations of species or on
BV status by Nugent scoring. On the contrary, in the ref-
erence group, a negative association with A. vaginae and
a positive association with Lactobacillus genus were
present among those who reported cleansing during
bathing. A systematic review of longitudinal studies con-
cluded that intravaginal cleansing with soap was associ-
ated with the development of intermediate vaginal flora
and bacterial vaginosis in women with normal vaginal
flora at baseline (pooled adjusted odds ratio 1.24, 95% CI
1.04–1.47) [55]. However, there is also evidence that
vaginal practices are highly heterogeneous and, therefore
different study populations use different practices and
products [56]. Indeed, women in this study mostly per-
formed washing with water during bathing as opposed to
using soap or detergents, which may explain our findings.
Although our data showed a link between the presence
of E. coli and intermediate BV (p = 0.011) there is yet no
evidence that E. coli is a regular member of the dysbiotic
bacterial community. In a recent review by van de
Wijgert and colleagues, only three molecular studies
reported vaginal microbiome clusters dominated by
streptococci, staphylococci, and/or E. coli [43,57,58]. It
is possible that the association between E. coli and BV
is confounded by unprotected sex. A study among 44
East African sex workers showed four types of micro-
biota of which one was dominated by E. coli, mostly
present in HIV-positive women, and was distinct from
BV [59]. Further, early culture-based studies docu-
mented that intercourse led to an increase in vaginal
E. coli [60]. This theory could explain the high pres-
ence of E. coli (70%) in the sex worker group in our
study. Additionally, the higher presence of E coli in
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tices such as anal sex in addition to perianal contam-
ination during vaginal intercourse [61].
This study has several strengths; sampling from
women in three different African countries; sampling
populations of women at different risks for STI and
HIV; and a quantitative estimation of abundance for
well-known dominant organisms of the vaginal micro-
biota which allowed for extensive profiling of a relatively
large number of samples. This study also has several
limitations: the sample size of the subgroups was small
compared to the large reference groups; the analysis was
cross-sectional; multiple testing was performed in defining
associations between the variables and species; co-linearity
was present e.g. age and parity were correlated (r = 0.65),
complicating the interpretation of independent effects.
Consequently, causation and effects of single associations
should be interpreted cautiously. Furthermore, we
excluded correlated variables and we did not correct for
multiple testing as this was a hypothesis generating ana-
lysis. Importantly, the study did not aim to investigate the
function of species or sub-species.Conclusion
In conclusion, our study in sub-Saharan women provides
important baseline data for several important species re-
lated to a healthy and dysbiotic vaginal microbiota. Our q
PCR results highlight the similarity of Lactobacillus genus
and species concentration across two East Africa and one
South African site, and between different sub-groups of
women. There were also some important differences by
pregnancy status and sexual behaviour. Unsurprisingly, we
found high concentrations of L. iners; but we also found a
high concentration of L. vaginalis which has not been well
described in other reports. We detected an overall lower
presence of Lactobacillus species compared to Asian, US
and European populations. These data may explain some
of the increased vulnerability of these populations to STI
including HIV. Longitudinal studies are needed to study
health outcomes, including acquisition of STI and HIV.
Additionally, research is needed to understand the role
and function of different microbial species and sub-
species (e.g. G. vaginalis) in relation to the protection and
susceptibility to infection. Ultimately, these data stress the
need to invest more research in order to develop novel
methods to improve reproductive health and the preven-
tion of infection.Additional files
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